Thanks to a $20.6M investment from CIHR, the Canadian Consortium on Neurodegeneration in Aging is embarking on its third phase to continue important and meaningful research. The nominated principal investigator of the grant is CCNA’s Scientific Director, Dr. Howard Chert...
After Launching Largest Canadian Dementia Study – COMPASS-ND – the Canadian Consortium on Neurodegeneration in Aging (CCNA) holds 2nd Annual Events Dementia has no cure and 25 000 Canadians are diagnosed annually. In an effort to accelerate breakthroughs in dementia services a...
Le Bulletin des stagiaires du CCNV *Un récapitulatif des nouvelles, événements, activités et réalisations à l’intention des stagiaires du CCNV Félicitations aux stagiaires du CCNV qui ont remporté une bourse de voyage IRSC-CCNV pour assister à la Journée scientifique et au For...
To mark World Alzheimer’s Day (September 21, 2016), the Canadian Consortium on Neurodegeneration in Aging (CCNA) is launching its signature clinical study, the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND). Over the next two years, the study will enro...
Although advanced age remains the “most potent risk factor for dementia,” it does not fully account for the incidence and severity of the disease, according to Drs. Melissa Andrew, Kenneth Rockwood, and colleagues in CCNA’s Team 14. With an eye to understanding h...
Now Accepting Applications Canadian Consortium on Neurodegeneration in Aging (CCNA) Training Awards Applications must be submitted by Monday, November 7, 2016 The Alzheimer Society Research Program is now accepting applications for the 2017 ASRP-CCNA Research Competition. The ...
THE CCNA TRAINEE DIGEST *A rundown of CCNA trainee news, events, activities, and accomplishments Congratulations to CCNA trainees awarded a CIHR-CCNA Travel Award to attend the CCNA Science Day and Partners Forum in Vancouver, October 5-7, 2016. Leslie Malloy-Weir – Team...
$2.3 million CIHR grant funding research to improve quality and appropriateness of services in rural areas. According to the Alzheimer Society of Canada, there are close to 564,000 Canadians living with dementia. This number is expected to increase by 66% over the next 15 yea...
“It’s unlikely that any therapy will be effective after the clinical presentation of Alzheimer’s disease. The best chance we have to alter its course is to intervene at earlier stages.” Dr. A. Claudio Cuello Alzheimer’s disease develops decades before it can be clinically dete...